Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Scisparc Ltd (SPRC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Scisparc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.260000 -0.110000    -8.03%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
1.360000
+0.100000
+7.936509%
19:29:58 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 256,002
  • Bid/Ask: 0.000000 / 0.000000
  • Day's Range: 1.230000 - 1.410000
Scisparc 1.260000 -0.110000 -8.03%

Scisparc Ltd Company Profile

 
Get an in-depth profile of Scisparc Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

3

Equity Type

ORD

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer’s to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer’s disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Contact Information

Address Tower A 2nd Floor
20 Raul Wallenberg Street Tel Aviv, 6971916
Israel
Phone 972 7 334 47180
Fax -

Top Executives

Name Age Since Title
Avi Weizman - 2016 Member of Scientific Advisory Board
Kirsten Müller-Vahl - 2016 Member of Scientific Advisory Board
Joseph Tam - - Member of Scientific Advisory Board
Daniele Piomelli - - Member of Scientific Advisory Board
Mellar P. Davis - - Member of Scientific Advisory Board
Michael H. Bloch - 2016 Member of Scientific Advisory Board
Alon Dayan 46 2021 Independent Director
Amitai Weiss 62 2020 Chairman of the Board
Moshe Revach 47 2020 Independent Director
Itschak Shrem 77 2020 President & Director
Michael Davidson 74 2016 Member of Scientific Advisory Board
Elon Eisenberg - - Member of Scientific Advisory Board
Lior Vider 48 2020 Independent Director
Liat Sidi 49 2020 Independent Director
Saoirse O'Sullivan - - Member of Scientific Advisory Board
Amnon Ben Shay 60 2021 Independent Director
Avi Schroeder - - Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SPRC Comments

Write your thoughts about Scisparc Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rehan Khan
Rehan Khan Jan 24, 2024 9:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hlwsir
Jack Belforte
Jack Belforte Mar 06, 2023 8:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SPRC good news.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email